| |
| |
|
| Insider
Information: |
Walker Neal |
| Relationship: |
|
| City: |
Burlington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,301,542 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,605,132 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,301,542 |
|
|
| Total
Value |
$1,605,132 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -201.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aldeyra Therapeutics, Inc. |
ALDX |
|
2023-08-22 |
15,854 |
2014-05-07 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
|
2024-04-01 |
1,285,688 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRS |
Aclaris Therapeutics, Inc... |
INTERIM PRESIDENT AND CEO |
• • – |
2024-04-01 |
4 |
D |
$1.26 |
$4,062 |
D/D |
(3,224) |
1,285,688 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
INTERIM PRESIDENT AND CEO |
• • – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,467 |
1,288,912 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Interim President and CEO |
• • – |
2024-03-01 |
4 |
D |
$1.24 |
$3,997 |
D/D |
(3,223) |
1,279,445 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Interim President and CEO |
• • – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,466 |
1,282,668 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
|
– • – |
2023-08-22 |
4 |
OE |
$0.55 |
$5,301 |
D/D |
9,604 |
15,854 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-03-03 |
4 |
S |
$12.63 |
$382,070 |
D/D |
(30,240) |
1,273,202 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-03-02 |
4 |
S |
$12.37 |
$358,588 |
D/D |
(29,000) |
1,285,188 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,254 |
1,303,442 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
138,425 |
1,314,188 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-02-02 |
4 |
AS |
$14.57 |
$81,248 |
D/D |
(5,000) |
1,175,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-02-01 |
4 |
AS |
$16.75 |
$418,675 |
D/D |
(25,000) |
1,180,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-01-04 |
4 |
AS |
$14.89 |
$223,343 |
D/D |
(15,000) |
1,205,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
Director |
– • – |
2023-01-03 |
4 |
AS |
$15.19 |
$381,213 |
D/D |
(25,000) |
1,220,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-04-25 |
4 |
AS |
$15.18 |
$303,656 |
D/D |
(20,000) |
1,245,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-04-22 |
4 |
AS |
$15.04 |
$376,098 |
D/D |
(25,000) |
1,265,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-04-21 |
4 |
AS |
$15.24 |
$380,948 |
D/D |
(25,000) |
1,290,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-03-11 |
4 |
S |
$15.91 |
$896,045 |
D/D |
(56,303) |
1,315,763 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,254 |
1,372,066 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
114,425 |
1,353,812 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-02-09 |
4 |
S |
$12.66 |
$45,513 |
D/D |
(3,595) |
1,239,387 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,800 |
1,242,982 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2021-06-02 |
4 |
S |
$21.51 |
$719,735 |
D/D |
(33,260) |
1,232,182 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
73,015 |
1,265,442 |
0 |
- |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2021-04-22 |
4 |
AS |
$26.84 |
$805,239 |
D/D |
(30,000) |
1,192,427 |
0 |
% |
|
| ACRS |
Aclaris Therapeutics, Inc... |
President and CEO |
• • – |
2021-03-02 |
4 |
D |
$23.25 |
$185,582 |
D/D |
(7,982) |
1,222,427 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
